AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 MAR 28 - (NewsRx.com & NewsRx.net) --
Trials aimed at developing vaccine against the HIV virus are failing to address the needs of millions of Africans at risk for the disease, an expert from Harvard University told a panel discussion at United Nations Headquarters in New York on March 12, 2001.
Speaking at the event jointly sponsored by the UN World Health Organization (WHO) and the International Health Awareness network, Dr. Seyou Ayehunie stressed that in order to fully understand the spread of AIDS in Africa in all its dimensions it was important to understand the strains of the HIV virus that were prevalent on the continent.
He noted that there were several subtypes of HIV in Africa, but the "most fierce by far" was subtype C, which now accounted for more infections than all others combined.
Ayehunie pointed out that more than 90% of current vaccine designs are based on viruses that are endemic in the West, but type C, which causes 90% of all infections in Africa and 75% worldwide, represents only 5% of vaccine trials. "I say that is wrong," Ayehunie told the panel.
The expert also stressed the need to provide Africa with medicines used to treat AIDS and related opportunistic infections. On this matter, he said, "the most important basic issue is cost."
Triple drug therapies used to treat AIDS patients cost ...
Source: HighBeam Research, Trials Fail To Address Africa's Needs, Harvard Expert Tells UN...